A synthetic peptide for use as a blocking control in assays to test for specificity of GCET2 antibody, Alternative Names: GCET2 control peptide, GCET2 antibody Blocking Peptide, Anti-GCET2 Blocking Peptide, Germinal Center Expressed Transcript 2 Blocking Peptide, GCAT2 Blocking Peptide, HGAL Blocking Peptide, MGC40441 Blocking Peptide
GCET2
Reaktivität: Drosophila melanogaster, Human
Wirt: Synthetic
BP, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
GCET2
(Germinal Center Expressed Transcript 2 (GCET2))
Synonyme
Gcet Peptide, Gcet2 Peptide, M17 Peptide, M17-L Peptide, GCAT2 Peptide, GCET2 Peptide, HGAL Peptide, germinal center associated, signaling and motility Peptide, germinal center associated signaling and motility Peptide, germinal center-associated, signaling and motility Peptide, Gcsam Peptide, GCSAM Peptide
Hintergrund
GCET2 is a protein which may function in signal transduction pathways and whose expression is elevated in germinal cell lymphomas. It contains a putative PDZ-interacting domain, an immunoreceptor tyrosine-based activation motif (ITAM), and two putative SH2 binding sites. In B cells, its expression is specifically induced by interleukin-4.